Bank Brussels Lambert v. Credit Lyonnais (Suisse), S.A.

210 F.R.D. 506, 2002 U.S. Dist. LEXIS 20505, 2002 WL 31409415
District Court, S.D. New York·Decided October 23, 2002·No. No. 93 Civ. 6876(LMM)(RLE)·Published·Cited by 7 cases

Opinion

OPINION & ORDER

ELLIS, United States Magistrate Judge.

I. INTRODUCTION

Before this Court is a motion by third-party defendant Roger & Wells (“R & W”) pursuant to Rules 26 and 37 of the Federal Rules of Civil Procedure to compel third-party plaintiff Credit Lyonnais Suisse (“CLS”) to produce certain documents prepared by CLS’s in-house counsel and outside counsel when R & W represented CLS in defending this action by various lenders to AroChem Corporation (“AroChem”). CLS claims that these documents are protected by the attorney-client privilege and are entitled to work product protection. For the following reasons, the Court finds that CLS has waived both the attorney-client privilege and work product protection by placing these documents “at issue.”

II. BACKGROUND

The facts of this action have been set forth in Bank Brussels Lambert, et al. v. Credit Lyonnais (Suisse), et al., 220 F.Supp.2d 283 (S.D.N.Y.2002). Briefly summarized, in May 1991, AroChem International Ltd. (“AIL”) requested financing from CLS of certain transactions involving back-to-back contracts for the purchase and sale of oil in the United States. Memorandum of Law of Third-Party Defendant Rogers & Wells’ Motion to Compel the Production of Documents (“Def.Mem.”) at 2. At that time, CLS retained R & W to advise it on the proposed financings and to document the financings in order to properly perfect CLS’s first priority security interest. Id. In October 1993, Bank Brussels Lambert, Swiss Bank Corporation, Banque Indosuez, and Skopbank (hereinafter, “the RCA Banks”) commenced litigation (“the underlying litigation”) against CLS alleging that it had violated RICO and intentionally committed fraud, conversion, and other common law torts when it financed the [508]*508contracts assigned to AIL by AroChem. Id. After consulting with and being advised by its in-house counsel, CLS retained R & W to act as lead counsel in the underlying litigation. Id. R & W defended CLS in the underlying litigation until December 1994. Memorandum of Law of Credit Lyonnais (Suisse) S.A. in Opposition to Rogers & Wells’ Motion to Compel the Production of Documents (“PI. Mem.”) at 2.

While R & W was defending CLS in the underlying litigation, CLS also consulted with other counsel, including its in-house counsel, in-house counsel at its parent company, and the Swiss firm of Lachenal Breeh-bühl, Cottier & Roguet (the “Cottier firm”). Id. at 3. In May, 1994, CLS also hired Kevin MacCarthy & Associates (the “MacCarthy firm”) to work with R & W. Id. CLS would generate documents regarding the underlying litigation, and then distill the information to R & W through its in-house counsel and the Cottier firm. Id. at 11. CLS also instructed R & W to communicate with it through its other attorneys throughout the underlying litigation. Def. Mem. at 4. R & W did so until the MacCarthy firm was engaged as liaison counsel to R & W to provide “another voice in connection with the representation of [CLS] in the AroChem matter.” Id.

On July 7, 1995, CLS filed a third-party complaint against R & W alleging: (1) malpractice and breach of contract on its advice about the AIL financings in 1991; and (2) breach of fiduciary duty, fraud, and breach of contract in connection with its defense of this action during the period from October 1, 1993, until CLS terminated R & W’s representation .in December 1994. Id. at 5. CLS alleges that during this latter period, R & W concealed from CLS its own malpractice in 1991, and concealed from CLS the extent and significance of its representation or attempted representation of other parties contemporaneously adverse to CLS. Id. CLS has alleged that during the underlying litigation, R & W interviewed Kikka Harrison, an account officer of CLS, and manipulated the interview to protect its own interests. Id.

R & W seeks certain documents exchanged between CLS and its various counsel both while CLS considered the AroChem financing and during the underlying litigation. R & W claims that these documents will aid in its defense, prove it did not defraud CLS and prove CLS’s state of mind during the crucial events of the underlying litigation. CLS claims that its case against R & W is not so broad as to encompass any of the documents on its privilege log. CLS claims that its state of mind is of little consequence to its claims against R & W.

III. DISCUSSION

A. Attorney-Client Privilege and Work Product Immunity

The attorney-client privilege is a legal doctrine that is often litigated and little understood. The purpose of the privilege is “to encourage full and frank communication between attorneys and their clients and thereby promote broader public interests in the observance of law and administration of justice.” Upjohn Co. v. United States, 449 U.S. 383, 389, 101 S.Ct. 677, 66 L.Ed.2d 584 (1981). However, because the privilege “stands in derogation of the public’s ‘right to every man’s evidence, ... it ought to be strictly confined within the narrowest possible limits consistent with the logic of its principle.’” In re Grand Jury Proceedings, 219 F.3d 175, 182 (2d Cir.2000) (citation omitted). Accordingly, the privilege will only attach “(1) [w]here legal advice of any kind is sought (2) from a professional legal advisor in his capacity as such, (3) the communications relating to that purpose, (4) made in confidence (5) by the client, (6) are at his instance permanently protected (7) from disclosure by himself or the legal advisor, (8) except the protection be waived[.]” United States v. International Brotherhood of Teamsters, 119 F.3d 210, 214 (2d Cir.1997)(qouting In re Grand Jury Subpoena Duces Tecum, 731 F.2d 1032, 1036 (2d Cir.1984)). Under the Federal Rules of Evidence 501, when parties are litigating state law claims, the state law defines the elements of attorney-client privilege. Therefore, under New York law, the party invoking the privilege “must demonstrate that the information at issue was a communication between client and counsel or his employee, [509]*509that it was intended to be and was in fact kept confidential, and that it was made in order to assist in obtaining or providing legal advice or services to the client.” Bowne of New York City, Inc. v. AmBase Corporation, 150 F.R.D. 465, 470-71 (S.D.N.Y.1993).

Unlike the invocation of the attorney-client privilege, work product immunity is governed by federal law. Id. Federal Rules of Civil Procedure

Free access — add to your briefcase to read the full text and ask questions with AI

Bank Brussels Lambert v. Credit Lyonnais (Suisse), S.A., 210 F.R.D. 506, 2002 U.S. Dist. LEXIS 20505, 2002 WL 31409415 (S.D.N.Y. 2002).

210 F.R.D. 506 (Bank Brussels Lambert v. Credit Lyonnais (Suisse), S.A.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Windsor Securities, LLC v. Arent Fox LLP
273 F. Supp. 3d 512 (S.D. New York, 2017)
Gingrich v. Sandia Corporation
2007 NMCA 101 (New Mexico Court of Appeals, 2007)
Blue Lake Forest Products, Inc. v. United States
75 Fed. Cl. 779 (Federal Claims, 2007)
Calabro v. Stone
225 F.R.D. 96 (E.D. New York, 2004)
Grinnell Corp. v. ITT Corp.
222 F.R.D. 74 (S.D. New York, 2003)